SAO PAULO, Oct 21 (Reuters) - Shares in Canada’s Knight Therapeutics were up 9% in Toronto after the announcement of acquisition of Latin American pharmaceutical company Biotoscana Investments earlier on Monday.
Shares in Biotoscana were also up 4.9% at 10.26 reais in mid-morning trading in Sao Paulo. In a securities filing, Knight said will acquire a 51% interest in Biotoscana for 596 million reais ($144 million), paying 10.26 reais per share. ($1 = 4.1366 reais) (Reporting by Tatiana Bautzer; editing by David Evans)
Our Standards: The Thomson Reuters Trust Principles.